Capacity and Citeline Connect collaborate to boost clinical trial recruitments, accelerating Moderna’s COVID-19 vaccine work

Capacity, an AI-powered support automation platform, is partnering with Citeline Connect, the all-in-one clinical trial recruitment platform developed by Informa Pharma Intelligence, to launch Moderna’s clinical trial recruitment website.

This partnership enables customers like Moderna to create engaging clinical trial recruitment websites. With the power of Capacity’s chatbot and support automation software alongside Citeline Connect technology, users are able to actively complete registration and pre-screening through an easy-to-use interface.

“Our work with Citeline Connect is reflective of our ultimate goal at Capacity, leveraging a company’s existing knowledge base with support automation to help teams do their best work,” said David Karandish, CEO of Capacity. “As we see relief from the COVID-19 pandemic on the horizon, there is still a way to go before we are in the clear. In working with Citeline Connect, we’re honored to have the opportunity to provide helpful technology for healthcare providers, researchers, and patients.”

Capacity and Citeline Connect’s work will enhance the patient experience, according to the vendors. With user-friendly technology, Capacity’s chatbot provides an expansive knowledge-base and user-friendly solution.

“We are proud of our ability to create more opportunities for the public to engage with important clinical trials,” said Chris Venezia, chief commercial officer at Citeline Connect. “Working with Capacity is a no-brainer to provide an extensive solution that meets the needs of potential patients and the clinical trial sponsors. They make it easy for both potential and current study participants to ask questions, find clinical trial information, and begin their study enrollment journey”

For more information about this news, visit https://capacity.com/ or https://pharmaintelligence.informa.com/.

KMWorld Covers
for qualified subscribers
Subscribe Now Current Issue Past Issues
Companies and Suppliers Mentioned